Friday, June 03, 2016
Cancer programs at Grosse Pointe, Royal Oak and Troy achieve gold rating
The Commission on Cancer, or CoC, of the American College of Surgeons has granted three-year accreditation with gold level commendation to Beaumont hospitals in Grosse Pointe, Royal Oak and Troy as an Integrated Network Cancer Program.
To earn voluntary CoC accreditation, a cancer program must meet or exceed 34 CoC quality care standards, be evaluated every three years through a survey process and maintain levels of excellence in the delivery of comprehensive patient-centered care. Three-year accreditation with commendation is only awarded to a facility that exceeds standard requirements at the time of its survey.
“We’re pleased with the results of the April survey. It validates our cancer program’s breadth; as well as our multidisciplinary team’s efforts to continually improve patient care,” said Thomas Lanni, vice president, Oncology, Medicine and Imaging, Beaumont Hospital, Grosse Pointe, Royal Oak and Troy. “The seven commendations make us eligible for the Outstanding Achievement Award given out at the end of the year.”
The CoC Accreditation program provides the framework for Beaumont Health’s cancer program to improve its quality of patient care through various cancer-related programs that focus on the full spectrum of cancer care, including:
- prevention
- early diagnosis
- cancer staging
- optimal treatment
- rehabilitation
- life-long follow up
- end-of-life care
“When patients receive care at a CoC facility, they also have access to information on clinical trials and new treatments,” explained Lanni. “In addition, they have the benefit of genetic counseling and patient-centered services, including psycho-social support, a patient navigation process and a survivorship care plan.”
CoC-accredited cancer programs offer patients:
- quality care close to home
- comprehensive care
- a multidisciplinary, team approach
- information and education
- patient-centered services
- options for genetic assessment and counseling, and palliative care services
- care monitoring and quality improvement
- treatment planning based on evidence-based national treatment guidelines
- clinical trials and new treatment options
- follow-up care including a survivorship care plan
- patient tracking through the cancer data system
Like all CoC-accredited facilities, Beaumont’s cancer program maintains a registry and contributes data to the National Cancer Data Base, a joint program of the CoC and American Cancer Society. This nationwide oncology outcomes database is the largest clinical disease registry in the world. Data on all types of cancer are tracked and analyzed through the NCDB and used to explore trends in cancer care.
There are currently more than 1,500 CoC-accredited cancer programs in the U.S. and Puerto Rico, representing 30 percent of all hospitals. CoC-accredited facilities diagnose and/or treat more than 70 percent of all newly diagnosed cancer patients. When cancer patients choose to seek care locally at a CoC-accredited cancer center, they are gaining access to comprehensive, state-of-the-art cancer care close to home. The CoC provides the public information on the resources, services and cancer treatment experience for each CoC-accredited cancer program.
Along with the three Beaumont hospitals recently surveyed – Grosse Pointe, Royal Oak and Troy – the cancer programs at Beaumont, Dearborn and Farmington Hills have also earned CoC accreditation.
Established in 1922 by the American College of Surgeons, the CoC is a consortium of professional organizations dedicated to improving patient outcomes and quality of life for cancer patients through standard-setting, prevention, research, education and the monitoring of comprehensive, quality care. Its membership includes Fellows of the American College of Surgeons. For more information, visit www.facs.org/cancer.